She underwent wide local excision, skin flap and right inguinal sentinel lymph node biopsy without residual melanoma at the primary site.
Dr. [**Last Name (STitle) **] performed a right superficial inguinal femoral lymphadenectomy with right sartorius rotation flap on [**2106-7-16**] with pathology showing microscopic melanoma in [**12-22**] residual lymph nodes.
She underwent skin biopsy of a left posterior thigh lesion in [**2107-1-12**] revealing a 0.62-mm thick superficial spreading melanoma, [**Doctor Last Name 10834**] level IV without ulceration for which she underwent re-excision on [**2107-2-2**] without residual melanoma noted.
She underwent CT-guided biopsy of a pelvic node revealing metastatic melanoma.
She was screened for high- dose IL-2 therapy and underwent prescreening testing.
She now is admitted to begin cycle 1 week on high-dose IL-2 therapy.
PAST MEDICAL HISTORY:  Cervical dysplasia treated with colonoscopy, cervical neck disk disease treated with surgery, lumbar spine disk herniation, a history of depression.
MEDICATIONS ON ADMISSION:  Wellbutrin SR 200 mg daily, Klonopin 0.5 mg at bedtime, 0.25 mg t.i.d.
p.r.n., Premarin 0.625 mg cream, Lexapro 20 mg daily, Nexium 40 mg p.o.
daily, lorazepam 1 mg t.i.d.
p.r.n., Percocet 1-2 tablets every 4 hours p.r.n.
pain, calcium 500 mg daily, multivitamin 1 tablet daily.
HOSPITAL COURSE:  Ms. [**Known lastname 63364**] was admitted and underwent central line placement to begin therapy.
Her admission weight was 68 kg and she received interleukin II 600,000 international units per kilo equaling 40.8 million units IV every 8 hours times 14 potential doses.
Chest x-ray was consistent with that and she was treated with Lasix with good urine output.
That night on treatment day #7 she desatted to 80% on a non-rebreather and was transferred to the ICU where continued diuresis was carried out.
She slowly improved with diuresis and was transferred back to 7 [**Hospital Ward Name 1950**] on [**1-22**] where she continued to improve with eventual discharge on [**2110-1-24**].
Other side effects during IL-2 therapy included rigors improved with Demerol; development of an erythematous pruritic skin rash; mild nausea improved with antiemetic therapy; and diarrhea improved with Lomotil therapy.
She was anemic without need for packed red blood cell transfusion.
DISCHARGE DIAGNOSES:  Metastatic melanoma status post cycle 1 week on high-dose IL-2 therapy complicated by acute pulmonary edema.
DISCHARGE MEDICATIONS:  Wellbutrin 200 mg p.o.
daily, Nexium 40 mg p.o.
daily, Lexapro 20 mg p.o.
daily, Percocet 1-2 tablets every 4 hours p.r.n.
pain,  Ativan 1 mg every 6 hours p.r.n.
Week 2 of therapy will not be administered at this time but we will plan to follow up with CT scans at week 7 to assess disease response to determine whether treatment again would be warranted.
